We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
The role of asymmetric dimethylarginine and arginine in the failing heart and its vasculature.
- Authors
Visser, Marlieke; Paulus, Walter J; Vermeulen, Mechteld A R; Richir, Milan C; Davids, Mariska; Wisselink, Willem; de Mol, Bas A J M; van Leeuwen, Paul A M
- Abstract
Nitric oxide (NO) is formed from arginine by the enzyme nitric oxide synthase (NOS). Asymmetric dimethylarginine (ADMA) can inhibit NO production by competing with arginine for NOS binding. Therefore, the net amount of NO might be indicated by the arginine/ADMA ratio. In turn, arginine can be metabolized by the enzyme arginase, and ADMA by the enzyme dimethylarginine dimethylaminohydrolase (DDAH). While ADMA has been implicated as a cardiovascular risk factor, arginine supplementation has been indicated as a treatment in cardiac diseases. This review discusses the roles of ADMA and arginine in the failing heart and its vasculature. Furthermore, it proposes nutritional therapies to improve NO availability.
- Publication
European journal of heart failure, 2010, Vol 12, Issue 12, p1274
- ISSN
1879-0844
- Publication type
Journal Article
- DOI
10.1093/eurjhf/hfq158